A simple pill might help stop nightmares before they start.
Researchers at the University of Florida have found that people who took the antidepressant Prozac after suffering serious injuries reported fewer symptoms of post-traumatic stress disorder (PTSD) and lower levels of pain over the following year. PTSD is a mental health condition that can develop after scary or dangerous experiences, causing nightmares, anxiety, and flashbacks.
The study, published in the Journal of Orthopaedic Trauma, enrolled 68 people who came to the UF Health Shands Level I Trauma Center in Gainesville with serious injuries like broken limbs or pelvic fractures. The participants were randomly split into two groups: one took the actual medication (fluoxetine, the generic name for Prozac) while the other took a calcium supplement for comparison. Neither group knew which they were receiving. Researchers then tracked their mental health for a full year.
The results were striking. People taking Prozac showed a clear decline in PTSD symptoms over the 12 months, while symptoms in the calcium group stayed roughly the same. About half of all trauma patients experience some form of mental health decline after their injuries, according to the researchers, making this finding particularly significant.
Dr. Jennifer Hagen, a professor of orthopedic surgery at the University of Florida who led the study, said the goal is to protect patients' mental health before problems develop, not just treat them after the fact. "We want to actually try and prevent or mitigate the symptoms before they happen, instead of reacting to their development," she said. "This is a shift in the thinking around pharmaceutical management of mental health."
The research team previously tried resiliency training programs to help trauma patients cope psychologically, but saw little measurable benefit. So they partnered with the Department of Psychiatry at UF to test whether Prozac, which is already approved to treat PTSD symptoms, could work preventatively when given right after an injury.
Diana Rijo, a research assistant and co-author of the study, noted that one of the biggest challenges was fighting stigma around mental health. "One of the biggest hurdles that we deal with in our studies is that mental health is very stigmatized in society," she said. To sidestep that barrier, researchers focused on relief from PTSD symptoms rather than diagnosing patients with anxiety or depression.
Because this was a small, unblinded study, the researchers caution that larger trials are needed to confirm the findings. They have already begun enrolling patients in a more rigorous, double-blind study where neither participants nor doctors know who receives the real medication. That kind of gold-standard study should provide clearer evidence about whether Prozac can genuinely help trauma patients ward off PTSD before it takes hold.
The ultimate aim, Dr. Hagen said, is to give trauma teams a simple tool to protect their patients' mental health alongside their physical recovery.